Related
A recent decision by Pres . Biden could set the stage for a likely Bachelor of Arts in Nursing on theApple Watchin the U.S. adopt a patent of invention dispute over the twist ’s ECG characteristic . TheApple Watch is the best - sell smart wearablein the world , with a 29.8 percentage global market part as of Q3 , 2022 , according to the IDC . The ECG feature film debuted with the Apple Watch Series 4 in 2018 and finally became a standard lineament of contend wearables , including Google ’s Pixel Watch and recent versions of Samsung ’s Galaxy Watch , among others .
grant to an proclamation byAliveCor , Pres . Biden has decline to veto a ruling by the International Trade Commission ( ITC ) that found Apple in violation of ECG patents held by a California - based medical technical school company address AliveCor . The ITC ’s ruling come last December when the system bring out a Limited Exclusion Order ( LEO ) and a cease and desist rules of order onthe sale of Apple Watches . AliveCor alleged that Apple infringed its ECG patent by using the technology in its smartwatches without permission .
Related : What Are Haptic Alerts On Apple Watch & Should You Enable Them ?
Potential Apple Watch Ban
AliveCor tell it first shared its ECG technology with Apple in 2015 , three year before it was introduced in the Apple Watch Series 4 . The technology has since found its way to all subsequent Apple Watch models , including the late flagship , the Apple Watch Ultra . In a assertion following the ITC ’s final ruling , AliveCor CEO Priya Abani hailed the conclusion and claimed that it will have wider repercussions beyond the confines of this caseful . She said,“This decision die beyond AliveCor and commit a clear message to innovators that the U.S. will protect patents to build and scale new technologies that benefit consumers . "
On the face of it , a potentialApple Watch ban in the U.S.could just be a thing of time . However , AliveCor has other upshot to come up to before the ITC ’s order can go into effect . The United States Patent Trial and Appeal Board had earlier void AliveCor ’s ECG patent that Apple is say to have go against . AliveCor has since appealed the ruling , and the Board is currently hear the case to see if the company ’s disceptation are valid . If the instrument panel ’s initial ruling is carry on , the Apple Watch will stay on sale in the country . However , if the ruling is in AliveCor ’s favor , it could have in mind trouble for Apple .
no matter of these opinion , theApple Watch is unlikely to be withdrawnfrom store shelves . If AliveCor get ahead the appeal , the two companies will probably talk terms a settlement that will call for Apple to pay royalties to use ECG tech in theApple Watch .
More : Can You Use An Apple Watch With An Android Phone ?
Source : AliveCor / PR Newswire
Photo: Brady Snyder
